Sign Up Today and Learn More About Sudo Biosciences Stock
Invest in or calculate the value of your shares in Sudo Biosciences or other pre-IPO companies through EquityZen's platform.
Sudo Biosciences Stock (SUDB)
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
About Sudo Biosciences Stock
Founded
2020
Headquarters
Carmel, IN, US
Industries
Software, Artificial Intelligence, Data and Analytics
Sudo Biosciences Press Mentions
Stay in the know about the latest news on Sudo Biosciences
Sudo Biosciences on LinkedIn: We are excited to announce a few new members of the Sudo Biosciences…
linkedin • Aug 03, 2024
Sudo Biosciences on LinkedIn: We are very pleased to announce another important addition to the Sudo…
linkedin • Jul 04, 2024
Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs ...
finance • Jun 05, 2024
Jennifer Jones on LinkedIn: Sudo Biosciences | Targeting Tyrosine kinase 2 | TYK2 therapeutics
linkedin • May 19, 2024
Sudo Biosciences on LinkedIn: We are pleased to announce expanded responsibilities for Imran B. and…
linkedin • May 19, 2024
Sudo Biosciences Management
Leadership team at Sudo Biosciences
CEO
Scott Byrd
Board Member
Shinichiro Fuse
Join now and verify your accreditation status to gain access to:
- Sudo Biosciences current valuation
- Sudo Biosciences stock price
- Available deals in Sudo Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Sudo Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Sudo Biosciences through EquityZen funds. These investments are made available by existing Sudo Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sudo Biosciences stock?
Shareholders can sell their Sudo Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
